Confusion after topical use of resorcinol. 1995

H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier

UI MeSH Term Description Entries
D012118 Resorcinols A water-soluble crystalline benzene-1,3-diol (resorcinol) and its derivatives. m-Dihydroxybenzenes,meta-Dihydroxybenzenes,m Dihydroxybenzenes,meta Dihydroxybenzenes
D003221 Confusion A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation. Confusional State,Bewilderment,Confusion, Post-Ictal,Confusion, Reactive,Disorientation,Confusion, Post Ictal,Confusional States,Post-Ictal Confusion,Reactive Confusion,State, Confusional,States, Confusional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
January 1950, Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
October 2019, International journal of cosmetic science,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
February 2002, The Annals of thoracic surgery,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
June 1981, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
January 1981, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
November 2016, The British journal of dermatology,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
May 2020, Dermatologic therapy,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
December 1996, The British journal of dermatology,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
February 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
H Bontemps, and M Mallaret, and G Besson, and H Bochaton, and F Carpentier
April 1985, American journal of ophthalmology,
Copied contents to your clipboard!